Oregon Public Employees Retirement Fund Increased Marriott International Cl A (MAR) Holding; Cambiar Investors Upped Its Acorda Therapeutics (ACOR) Holding

November 15, 2017 - By wolcottdaily

Oregon Public Employees Retirement Fund increased Marriott International Cl A (MAR) stake by 185.88% reported in 2017Q2 SEC filing. Oregon Public Employees Retirement Fund acquired 62,200 shares as Marriott International Cl A (MAR)’s stock rose 15.06%. The Oregon Public Employees Retirement Fund holds 95,663 shares with $9.60M value, up from 33,463 last quarter. Marriott International Cl A now has $44.87B valuation. The stock declined 0.03% or $0.04 reaching $123.02 on the news. About 8,316 shares traded. Marriott International Inc (NASDAQ:MAR) has risen 58.26% since November 15, 2016 and is uptrending. It has outperformed by 41.56% the S&P500.

Cambiar Investors Llc increased Acorda Therapeutics Inc (ACOR) stake by 3.07% reported in 2017Q2 SEC filing. Cambiar Investors Llc acquired 25,688 shares as Acorda Therapeutics Inc (ACOR)’s stock declined 39.72%. The Cambiar Investors Llc holds 861,331 shares with $16.97 million value, up from 835,643 last quarter. Acorda Therapeutics Inc now has $1.32B valuation. The stock declined 33.33% or $9.4 reaching $18.8 on the news. About 588,467 shares traded or 7.95% up from the average. Acorda Therapeutics Inc (NASDAQ:ACOR) has declined 40.68% since November 15, 2016 and is downtrending. It has underperformed by 57.38% the S&P500.

Cambiar Investors Llc decreased Bristol Myers Squibb Co (NYSE:BMY) stake by 378,937 shares to 753,509 valued at $41.99M in 2017Q2. It also reduced Travelport Worldwide Ltd (NYSE:TVPT) stake by 343,561 shares and now owns 1.54M shares. Third Pt Reins Ltd (NYSE:TPRE) was reduced too.

Among 12 analysts covering Acorda Therapeutics (NASDAQ:ACOR), 5 have Buy rating, 1 Sell and 6 Hold. Therefore 42% are positive. Acorda Therapeutics had 30 analyst reports since August 25, 2015 according to SRatingsIntel. The firm has “Hold” rating by Cantor Fitzgerald given on Tuesday, October 31. The firm has “Overweight” rating by JP Morgan given on Wednesday, November 30. The firm has “Buy” rating given on Tuesday, August 25 by Stifel Nicolaus. The company was initiated on Wednesday, March 30 by Goldman Sachs. Stifel Nicolaus maintained it with “Buy” rating and $26.0 target in Tuesday, August 29 report. The rating was upgraded by Janney Capital to “Buy” on Monday, March 13. On Tuesday, August 29 the stock rating was maintained by Leerink Swann with “Hold”. The stock of Acorda Therapeutics Inc (NASDAQ:ACOR) earned “Market Perform” rating by Raymond James on Tuesday, September 1. The stock of Acorda Therapeutics Inc (NASDAQ:ACOR) has “Buy” rating given on Tuesday, August 25 by TheStreet. On Tuesday, September 1 the stock rating was initiated by Aegis Capital with “Buy”.

Since June 16, 2017, it had 1 insider purchase, and 0 selling transactions for $338,998 activity. COHEN RON bought $338,998 worth of Acorda Therapeutics Inc (NASDAQ:ACOR) on Friday, June 16.

Investors sentiment increased to 1.25 in 2017 Q2. Its up 0.07, from 1.18 in 2017Q1. It improved, as 35 investors sold ACOR shares while 33 reduced holdings. 21 funds opened positions while 64 raised stakes. 49.07 million shares or 5.04% more from 46.72 million shares in 2017Q1 were reported. Macquarie Grp Incorporated Limited has 601,119 shares. State Street holds 0% of its portfolio in Acorda Therapeutics Inc (NASDAQ:ACOR) for 2.48 million shares. Dupont Cap Mgmt Corp invested in 33,997 shares. Sei Invs owns 5 shares for 0% of their portfolio. 10,100 are owned by Prelude Ltd. Deutsche Fincl Bank Ag holds 245,821 shares. Geode Cap Mngmt Limited Com reported 454,145 shares. Northern Tru Corp has 0% invested in Acorda Therapeutics Inc (NASDAQ:ACOR). Zurcher Kantonalbank (Zurich Cantonalbank) invested 0% of its portfolio in Acorda Therapeutics Inc (NASDAQ:ACOR). Arizona State Retirement accumulated 24,305 shares. Kentucky-based Teachers Retirement System Of The State Of Kentucky has invested 0% in Acorda Therapeutics Inc (NASDAQ:ACOR). Moreover, Invesco has 0% invested in Acorda Therapeutics Inc (NASDAQ:ACOR) for 565,719 shares. Guggenheim Capital Ltd Llc reported 104,183 shares. Piedmont Investment Advsrs Ltd holds 0% or 10,088 shares. Bnp Paribas Arbitrage Sa accumulated 0% or 14,057 shares.

Investors sentiment increased to 1.01 in 2017 Q2. Its up 0.08, from 0.93 in 2017Q1. It is positive, as 40 investors sold MAR shares while 226 reduced holdings. 87 funds opened positions while 181 raised stakes. 241.03 million shares or 2.97% less from 248.42 million shares in 2017Q1 were reported. Marsico Capital Mngmt Limited Company owns 33,630 shares for 0.14% of their portfolio. Maryland Cap Mngmt holds 2.64% of its portfolio in Marriott International Inc (NASDAQ:MAR) for 183,251 shares. Roundview Limited Liability Com invested in 3,085 shares. Lord Abbett And Commerce Ltd Limited Liability Company holds 0.13% or 430,323 shares in its portfolio. Rothschild Investment Corp Il has 0.07% invested in Marriott International Inc (NASDAQ:MAR) for 5,749 shares. Norinchukin Retail Bank The accumulated 21,561 shares. Bessemer Gp reported 810 shares stake. Paloma Partners Mngmt Co invested in 0.18% or 147,844 shares. Walleye Trading Llc has invested 0.08% in Marriott International Inc (NASDAQ:MAR). Peak6 LP invested 0.03% of its portfolio in Marriott International Inc (NASDAQ:MAR). Mufg Americas Hldgs owns 15,480 shares. Ahl Partners Llp reported 0.04% stake. Kentucky-based Kentucky Retirement Tru Fund has invested 0.15% in Marriott International Inc (NASDAQ:MAR). Pitcairn Commerce holds 0.07% or 5,822 shares. Exane Derivatives invested in 1 shares or 0% of the stock.

Oregon Public Employees Retirement Fund decreased Regency Centers Corp (NYSE:REG) stake by 38,848 shares to 11,400 valued at $714,000 in 2017Q2. It also reduced Endo International Plc (NASDAQ:ENDP) stake by 81,272 shares and now owns 73,989 shares. Chevron Corp (NYSE:CVX) was reduced too.

Since May 24, 2017, it had 0 insider buys, and 3 selling transactions for $1.02 million activity. The insider Ryan Edward A sold 3,300 shares worth $345,355. Another trade for 3,733 shares valued at $401,074 was sold by Marriott Stephen Blake. 2,589 shares valued at $273,544 were sold by Grissen David on Wednesday, May 24.

Among 18 analysts covering Marriott International (NASDAQ:MAR), 11 have Buy rating, 0 Sell and 7 Hold. Therefore 61% are positive. Marriott International had 52 analyst reports since August 5, 2015 according to SRatingsIntel. The firm earned “Overweight” rating on Thursday, November 9 by Morgan Stanley. The firm earned “Buy” rating on Monday, September 26 by Goldman Sachs. The firm earned “Buy” rating on Friday, December 4 by Canaccord Genuity. The rating was downgraded by Evercore to “Hold” on Monday, November 28. The firm has “Hold” rating by Robert W. Baird given on Tuesday, October 17. The firm has “Hold” rating given on Wednesday, June 21 by Stifel Nicolaus. The firm has “Buy” rating by SunTrust given on Thursday, September 24. The rating was maintained by Deutsche Bank on Monday, August 7 with “Hold”. The stock has “Hold” rating by SunTrust on Tuesday, February 21. RBC Capital Markets maintained the shares of MAR in report on Wednesday, November 4 with “Outperform” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 wolcottdaily




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: